NCT04472078View on ClinicalTrials.gov

Seroprevalence of Coronavirus Disease 2019 (COVID-19) Antibodies in a Vulnerable Neighbourhood, Buenos Aries Argentina

CompletedOBSERVATIONAL
Enrollment

873

Participants

Timeline

Start Date

June 10, 2020

Primary Completion Date

June 26, 2020

Study Completion Date

December 11, 2020

Conditions
SARS-CoV-2
Interventions
DIAGNOSTIC_TEST

Serological Assay or IgG for SARS-CoV-2

Serological Assay for detection of IgG for SARS-CoV-2

Trial Locations (1)

1425

Hospital de Niños Ricardo Gutierrez, Buenos Aires

All Listed Sponsors
collaborator

Hospital de Niños R. Gutierrez de Buenos Aires

OTHER

collaborator

Salud Comunitaria Ministerio de Salud GCBA

UNKNOWN

lead

Hospital Italiano de Buenos Aires

OTHER

NCT04472078 - Seroprevalence of Coronavirus Disease 2019 (COVID-19) Antibodies in a Vulnerable Neighbourhood, Buenos Aries Argentina | Biotech Hunter | Biotech Hunter